miércoles, 11 de marzo de 2026
Engineered immune cells target Alzheimer’s disease protein
Engineered immune cells target Alzheimer’s disease protein
At a Glance
Scientists designed a T cell that reduced signs of disease in the brains of a mouse model for Alzheimer’s disease.
With further development, this type of immunotherapy could one day help treat Alzheimer’s disease and some other brain disorders.
https://www.nih.gov/news-events/nih-research-matters/engineered-immune-cells-target-alzheimers-disease-protein
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario